Herlev Hospital

Futó vizsgálatok

• Még nem toboroz

  Sarcoma and Intra-infusion Exercise for Better Outcomes

  NCT07785882· Forrás

• Még nem toboroz

  Dose-Escalated Short-Course Proton Therapy for Locally Advanced Rectal Cancer

  NCT07903883· Forrás

• Toboroz

  Rituximab for Treatment of Checkpoint Inhibitor Induced Immune-related Adverse Events

  NCT07694414· 1. fázis· Forrás

• Toboroz

  A randomised active-controlled study to assess the safety and pharmacodynamics of two blinded doses of vortosiran and open-label apixaban in patients with non-valvular atrial fibrillation

  2026-525417-31-00· 2. fázis· Forrás

• Toboroz

  Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse

  NCT07871864· 3. fázis· Forrás

• Toboroz

  Feasibility of Automatic, Laser-based Distance Control in Persons With Superficial Bladder Tumors

  NCT07860398· Forrás

• Toboroz

  A Clinical Study to Compare BupiZenge With Lidocaine for Pain Due to Oral Mucositis in Patients With Head and Neck Cancer.

  NCT07672236· 3. fázis· Forrás

• Toboroz

  Neoadjuvant Immunotherapy for Patients With High-risk Eye Melanoma

  NCT07501117· 1. fázis· Forrás

• Toboroz

  Neoadjuvant nivolumab and ipilimumab for patients with high-risk uveal melanoma

  2025-524953-15-00· 1. fázis· Forrás

• Toboroz

  Crohn’s Head-to-Head Assessing Risankizumab Versus Guselkumab for One Year

  2025-521590-13-00· 3. fázis· Forrás

• Toboroz

  A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

  NCT07499232· 3. fázis· Forrás

• Toboroz

  QoLIDia: Quality of Life in Cancer Patients With Diabetes During Immunotherapy

  NCT07466212· Forrás

• Toboroz

  Comparing Hydrocortisone and Prednisolone for Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD)

  NCT06892210· 4. fázis· Forrás

• Még nem toboroz

  Neoadjuvant Immunotherapy and Organ-sparing Treatment in Patients With Stage I-III dMMR Colon Cancer

  NCT07409844· 2. fázis· Forrás

• Toboroz

  Evaluation of the Role of Luteinizing Hormone (LH) and Human Chorionic Gonadotropin (hCG) in Adult Patients Undergoing Assessment for Endocrine Disorders

  NCT07824102· Forrás

• Toboroz

  The CPH-MBD Cohort Dietary Substudy - Comparison of Methods for Dietary Registrations

  NCT07312981· Forrás

• Toboroz

  A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

  NCT06793215· 3. fázis· Forrás

• Toboroz

  An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)

  NCT07206056· 1/2. fázis· Forrás

• Toboroz

  A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

  NCT07144280· 3. fázis· Forrás

• Toboroz

  [68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in Cancer

  NCT07215182· 2. fázis· Forrás

• Toboroz

  Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

  NCT07044336· 3. fázis· Forrás

• Toboroz

  Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

  NCT06677060· 3. fázis· Forrás

• Toboroz

  Phase II randomized study evaluating a Pragmatic approach to Adoptive Cell Therapy (ACT) using an IL2 analog (ANV419/ANV600) vs High dose IL2 after Tumor Infiltrating Lymphocytes (TIL) Therapy in patients with melanoma, NSCLC and cervical cancer. The PragmaTIL

  2023-506400-99-00· 2. fázis· Forrás

• Toboroz

  T-cell Therapy with CRISPR PD1-edited Tumor Infiltrating Lymphocytes for Patients with Metastatic Melanoma

  NCT06783270· 1. fázis· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-risk Muscle-invasive Urothelial Carcinoma (MIUC)

  NCT06534983· 2. fázis· Forrás

• Fut, nem toboroz

  Continuous Glucose Monitoring in Dialysis Patients With Diabetes

  NCT06641765· Forrás

• Toboroz

  Optimal Diuretic Therapies for Acute Heart Failure With Volume Overload

  NCT06166654· 3. fázis· Forrás

• Toboroz

  ADP-TILIL7

  2023-509665-20-00· 1. fázis· Forrás

• Fut, nem toboroz

  A study comparing TAR-210 versus single agent treatment instilled directly into the bladder in people with bladder cancer with FGFR gene alterations.

  2023-507684-19-00· 3. fázis· Forrás

• Toboroz

  IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)

  NCT06112314· 3. fázis· Forrás

• Fut, nem toboroz

  Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)

  NCT06353386· 1/2. fázis· Forrás

• Toboroz

  Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  NCT05485961· 2/3. fázis· Forrás

• Toboroz

  A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

  NCT06319820· 3. fázis· Forrás

• Toboroz

  Integrated Approach in Frail Older People with Atrial Fibrillation

  NCT06775028· Forrás

• Fut, nem toboroz

  Study to Assess Speed of Onset and Durability of Effectiveness of Upadacitinib in Adult Participants With Moderate to Severe Crohn's Disease (CD) in Real World Clinical Practice.

  NCT05930275· Forrás

• Toboroz

  DESTINY Breast Respond HER2-(Ultra)Low Europe

  NCT05945732· Forrás

• Toboroz

  DECONGEST-AHF: Vasodilatation or Loop Diuretics in Acute Heart Failure

  NCT05276219· 4. fázis· Forrás

• Toboroz

  Rescue of Nephrons With ALE.F02 (RENAL-F02)

  NCT06047171· 2. fázis· Forrás

• Toboroz

  Does peri-operative treatment with Tranexamic Acid reduce the early relapse rate for patients with melanoma; a randomised controlled trial

  2022-502633-26-00· 3. fázis· Forrás

• Toboroz

  GUIDE.MRD-01-CRC: Clinical Validation and Benchmarking of Top Performing ctDNA Diagnostics - Colorectal Cancer

  NCT06111105· Forrás

• Toboroz

  DANISH.MRD: Danish Assessment of Minimal Residual Disease by Liquid Biopsies

  NCT06076811· Forrás

• Fut, nem toboroz

  A Clinical Study of Intismeran Autogene (V940) Plus Pembrolizumab in People With High-Risk Melanoma (V940-001)

  NCT05933577· 3. fázis· Forrás

• Meghívásos bevonás

  Long-term Extension Study to Assess Adverse Events of Oral Atogepant Tablets in Pediatric Participants (6 to 17 Years of Age) With Migraine

  NCT05707949· 3. fázis· Forrás

• Toboroz

  A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine

  NCT05711394· 3. fázis· Forrás

• Fut, nem toboroz

  A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation

  NCT05757869· 3. fázis· Forrás

• Fut, nem toboroz

  IMPROVE-pT1: Accurate Allocation of Completion Resection in Early Colorectal Cancer

  NCT06040632· Forrás

• Toboroz

  Stroke School -Including Physical Exercise, Patient Education and Individual Follow-up Sessions

  NCT04945174· Forrás

• Meghívásos bevonás

  Translating Genetic Knowledge Into Clinical Care in Non-Autoimmune Diabetes

  NCT05368220· Forrás

• Fut, nem toboroz

  The Diverticulitis Study

  NCT06023004· Forrás

• Toboroz

  A National Phase II Study of Proton Therapy in Hepatocellular Carcinoma

  NCT05203120· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Melanóma9 toboroz
• Szívelégtelenség5 toboroz
• Krónikus vesebetegség4 toboroz
• Vastagbélrák4 toboroz
• 2-es típusú cukorbetegség3 toboroz
• Hólyagrák3 toboroz
• Pitvarfibrilláció3 toboroz
• Prosztatarák3 toboroz
• Stroke (szélütés)3 toboroz
• Szarkóma3 toboroz
• Tüdőrák3 toboroz
• Crohn-betegség2 toboroz
• Krónikus obstruktív tüdőbetegség (COPD)2 toboroz
• Migrén2 toboroz
• Csontritkulás1 toboroz
• Fej-nyaki daganatok1 toboroz
• Gyermekkori daganatok1 toboroz
• Koszorúér-betegség1 toboroz
• Magas vérnyomás1 toboroz
• Máj- és epeúti rák1 toboroz
• Méhnyakrák1 toboroz
• Méhtestrák1 toboroz
• Petefészekrák1 toboroz
• Vesedaganat1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Lezárult

  ARIISE - ASCs in recently diagnosed non-ischemic heart failure

  NCT06840275· 2. fázis· Forrás

• Fut, nem toboroz

  Phase 2 Platform Study of Novel Immunotherapy Combinations as First-Line Treatment in Participants with PD-L1 Positive Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

  2023-503428-24-00· 2. fázis· Forrás

• Fut, nem toboroz

  Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005)

  NCT06132958· 3. fázis· Forrás

• Lezárult

  A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)

  NCT06077864· 3. fázis· Forrás

• Lezárult

  Orismilast for the treatment of moderate to severe ulcerative colitis

  2022-502763-37-02· 2. fázis· Forrás

• Lezárult

  A clinical trial to assess the safety and effects of AGMB-129 compared to placebo in patients with fibrostenotic Crohn’s disease.

  2022-502789-26-01· 2. fázis· Forrás

• Lezárult

  Phase II, multi‑cohort trial of neoadjuvant and post‑surgery IO102‑IO103 and pembrolizumab in patients with selected resectable tumors

  2022-502787-20-00· 2. fázis· Forrás

• Lezárult

  STENOVA - A Study to Evaluate Safety, Tolerability, PK and PD of AGMB-129 in Patients With Fibrostenotic Crohn's Disease

  NCT05843578· 2. fázis· Forrás

• Fut, nem toboroz

  A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

  NCT05702034· 3. fázis· Forrás

• Lezárult

  A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke

  NCT05686070· 3. fázis· Forrás

• Lezárult

  A study to learn how well the study treatment asundexian works and how safe it is compared to apixaban to prevent stroke or systemic embolism in people with irregular and often rapid heartbeat (atrial fibrillation), and at risk for stroke

  NCT05643573· 3. fázis· Forrás

• Lezárult

  En Bloc Transurethral Resection of Non-muscle Invasive Bladder Cancer

  NCT05223491· Forrás

• Lezárult

  Safety and Efficacy of Efavaleukin Alfa in Subjects with Moderately to Severely Active Ulcerative Colitis

  NCT04987307· 2. fázis· Forrás

• Lezárult

  A Study to Evaluate Safety, Pharmacokinetics, and Preliminary Clinical Activity of RO7276389 Alone and in Combination with Cobimetinib in Participants with BRAF-V600 Mutation-Positive Advanced Solid Tumor or BRAF-V600 Mutation-Positive Melanoma with Central Nervous System Metastases

  2023-506310-43-00· 1. fázis· Forrás

• Fut, nem toboroz

  Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma (MK-3475-C93/KEYNOTE-C93/GOG-3064/ENGOT-en15)

  NCT05173987· 3. fázis· Forrás

• Lezárult

  Adjuvant Immunotherapy with Nivolumab + Relatlimab Fixed-dose Combination versus Nivolumab Monotherapy after Complete Resection of Stage III-IV Melanoma

  NCT05002569· 3. fázis· Forrás

• Leállították

  The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis

  NCT04985968· 3. fázis· Forrás

• Lezárult

  A Study of Vericiguat (MK-1242) in Participants With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-035)

  NCT05093933· 3. fázis· Forrás

• Lezárult

  A Trial to Learn How Well Finerenone Works and How Safe it is in Adult Participants With Non-diabetic Chronic Kidney Disease

  NCT05047263· 3. fázis· Forrás

• Lezárult

  AI Augmented Training for Skin Specialists

  NCT04758988· Forrás

• Lezárult

  The Cardiac Effects of Empagliflozin in Patients With High Risk of Heart Failure

  NCT05084235· 2. fázis· Forrás

• Lezárult

  The Metabolic Effects of Empagliflozin in Patients With High Risk of Heart Failure

  NCT05042973· 2. fázis· Forrás

• Lezárult

  HOLT-ED: Holter-monitoring in End-stage Renal Disease

  NCT04876963· Forrás

• Lezárult

  Quantitative ICG Fluorescence Angiography in Colorectal Surgery

  NCT05153954· Forrás

• Lezárult

  Cardiac Arrhythmia in Patients With End-Stage Renal Disease

  NCT04841304· Forrás

• Lezárult

  When to INDuce for OverWeight? (WINDOW)

  NCT04603859· Forrás

• Leállították

  A Study of Atezolizumab in Combination With Cabozantinib Compared to Cabozantinib Alone in Participants With Advanced Renal Cell Carcinoma After Immune Checkpoint Inhibitor Treatment

  NCT04338269· 3. fázis· Forrás

• Lezárult

  Phase 3 Study of Pembrolizumab/Placebo plus Enzalutamide plus ADT in mHSPC

  NCT04191096· 3. fázis· Forrás

• Fut, nem toboroz

  A Study of Nivolumab, Nivolumab Plus Ipilimumab, or Investigator's Choice Chemotherapy for the Treatment of Participants With Deficient Mismatch Repair (dMMR)/Microsatellite Instability High (MSI-H) Metastatic Colorectal Cancer (mCRC)

  NCT04008030· 3. fázis· Forrás

• Lezárult

  Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866)

  NCT03924856· 3. fázis· Forrás

• Lezárult

  Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)

  NCT03867084· 3. fázis· Forrás

• Lezárult

  Study of First-line Pembrolizumab (MK-3475) With Lenvatinib (MK-7902/E7080) in Urothelial Carcinoma Cisplatin-ineligible Participants Whose Tumors Express Programmed Cell Death-Ligand 1 and in Participants Ineligible for Platinum-containing Chemotherapy (MK-7902-011/E7080-G000-317/ LEAP-011)

  NCT03898180· 3. fázis· Forrás

• Lezárult

  Surveillance With PET/CT and Liquid Biopsies of Stage I-III Lung Cancer Patients After Completion of Definitive Therapy

  NCT03740126· Forrás

• Lezárult

  A Dose Escalation and Expansion Study of Lomvastomig, a PD-1/TIM-3 Bispecific Antibody, in Participants With Advanced and/or Metastatic Solid Tumors

  NCT03708328· 1. fázis· Forrás

• Lezárult

  A prospective, multicenter, phase-II trial of ibrutinib plus venetoclax in physically fit patients with creatinine clearance ≥ 30 ml/min who have relapsed or refractory chronic lymphocytic leukemia (RR-CLL) with or without TP53 aberrations, HOVON 141 CLL / VIsion Trial of the HOVON and Nordic CLL study groups

  NCT03226301· 2. fázis· Forrás

• Lezárult

  A Study of Rucaparib Versus Physician's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency

  NCT02975934· 3. fázis· Forrás

• Lezárult

  Quality of Life the Danish Multiple Myeloma Patients

  NCT02892383· Forrás

• Lezárult

  Colchicine for Prevention of Vascular Inflammation in Non-cardio Embolic Stroke

  NCT02898610· 3. fázis· Forrás

• Lezárult

  A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)

  NCT02684006· 3. fázis· Forrás

• Lezárult

  Nivolumab Combined With Ipilimumab Versus Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma (CheckMate 214)

  NCT02231749· 3. fázis· Forrás

• Lezárult

  An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors

  NCT01968109· 1/2. fázis· Forrás

• Lezárult

  Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer

  NCT02003924· 3. fázis· Forrás

• Lezárult

  A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

  NCT01848561· Forrás

Vizsgálati helyszínek

• Herlev Hospital2 vizsgálat
• Afdeling for Kræftbehandling, Herlev Hospital1 vizsgálat
• Department of Endocrinology and Internal Medicine, Herlev Hospital1 vizsgálat
• Department of Nephrology, Herlev Hospital1 vizsgálat
• Department of Neurology, Herlev Hospital0 vizsgálat
• Department of Oncology, Herlev Hospital2 vizsgálat
• Department of Surgery, Herlev Hospital1 vizsgálat
• Department of Urology, Herlev Hospital1 vizsgálat
• Detp. of Pastic and Reconstructive Surgery, Herlev Hospital1 vizsgálat
• Duplicate_Herlev Hospital /ID# 2232210 vizsgálat
• Herlev Hospital94 vizsgálat
• Herlev Hospital - Afdeling for Hjertesygdomme, Forskning 10 vizsgálat
• Herlev Hospital, Afdeling for Kræftbehandling, Center for Kræftforskning, Klinisk Forskningsenhed1 vizsgálat
• Herlev Hospital-Department of Cardiology1 vizsgálat
• Herlev Hospital, Department of Oncology1 vizsgálat
• Herlev Hospital, Department of Urology1 vizsgálat
• Herlev Hospital, Dept Nephrology1 vizsgálat
• Herlev Hospital - Hjerne og Nervesygdomme0 vizsgálat
• Herlev Hospital /ID# 2007850 vizsgálat
• Herlev Hospital /ID# 2477240 vizsgálat
• Herlev Hospital /ID# 2477250 vizsgálat
• Herlev Hospital /ID# 2624871 vizsgálat
• Herlev Hospital /ID# 2704820 vizsgálat
• Herlev Hospital /ID# 2768310 vizsgálat
• Herlev Hospital /ID# 982391 vizsgálat
• Herlev Hospital, Onkologisk Afdeling R1 vizsgálat
• Herlev Hospital (Site 0251)1 vizsgálat
• Herlev Hospital (Site 0421)1 vizsgálat
• Herlev Hospital (Site 0681)1 vizsgálat
• Herlev Hospital (Site 0902)0 vizsgálat
• Herlev Hospital (Site 0903)0 vizsgálat
• Herlev Hospital (Site 1002)0 vizsgálat
• Herlev Hospital (Site 1700)0 vizsgálat
• Herlev Hospital (Site 2514)0 vizsgálat
• Herlev Hospital - University Copenhagen1 vizsgálat
• Herlev Hospital, University of Copenhagen1 vizsgálat
• Kobenhavns Universitet - Herlev Hospital (Amtssygehuset i Herlev)1 vizsgálat
• National Center for Cancer Immune Therapy, Department of Oncology, Herlev Hospital2 vizsgálat

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Melanóma57 munka · 18 vizsgálat
• Familiáris hiperkoleszterinémia4 munka · 0 vizsgálat